A detailed history of Insigneo Advisory Services, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Insigneo Advisory Services, LLC holds 9,424 shares of AZN stock, worth $842,505. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,424
Previous 8,131 15.9%
Holding current value
$842,505
Previous $568 Million 27.25%
% of portfolio
0.05%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$68.72 - $82.11 $88,854 - $106,168
1,293 Added 15.9%
9,424 $723 Million
Q2 2025

Aug 12, 2025

BUY
$64.87 - $75.0 $3,178 - $3,675
49 Added 0.61%
8,131 $568 Million
Q1 2025

Apr 17, 2025

SELL
$65.37 - $77.96 $2,614 - $3,118
-40 Reduced 0.49%
8,082 $594 Million
Q4 2024

Feb 13, 2025

SELL
$63.2 - $79.58 $106,176 - $133,694
-1,680 Reduced 17.14%
8,122 $532 Million
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $121,061 - $138,351
1,579 Added 19.2%
9,802 $764 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $93,400 - $113,000
-1,398 Reduced 14.53%
8,223 $652 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $587,169 - $669,332
9,621 New
9,621 $652 Million
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $66,341 - $73,349
1,023 Added 16.66%
7,162 $485 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $9,577 - $10,385
137 Added 2.28%
6,139 $439 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $7,893 - $8,950
125 Added 2.13%
6,002 $417 Million
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $318,592 - $413,975
5,877 New
5,877 $398 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Insigneo Advisory Services, LLC Portfolio

Follow Insigneo Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insigneo Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insigneo Advisory Services, LLC with notifications on news.